Hindustan Laboratories IPO IPO

Mainline[.] – [.]

Open

[.]

Allotment

—

Listing

[.]

Issue Size

1,41,00,000 shares (agg. up to ₹[.] Cr)

Listing Date

[.]

✦ AI Insight

Restated Financials (₹ Cr.)

Period Ended	30 Sep 2025	31 Mar 2025	31 Mar 2024	31 Mar 2023
Assets	242.95	225.49	176.35	145.40
Total Income	115.78	227.37	194.33	179.48
Profit After Tax	18.24	41.27	34.14	22.25
EBITDA	25.46	53.88	44.09	30.69
NET Worth	197.01	178.74	137.34	103.15
Total Borrowing	3.85	6.79	5.11	1.50
Amount in ₹ Crore

Peer Comparison

Company	Issue Type	Issue Size	Issue Price	PE Ratio	Listing Day Close	Listing Gain/Loss %	LTP
Symbiotec Pharmalab Ltd.	Mainboard	₹1,757.00 Cr	₹988	55.44	₹1,097.70	+11.10%	₹1,133.45
Hexagon Nutrition Ltd.	Mainboard	₹138.87 Cr	₹45	22.69	₹53.19	+18.20%	₹67.99
Sai Parenteral's Ltd.	Mainboard	₹408.79 Cr	₹392	72.19	₹405.70	+3.49%	₹523.35
Corona Remedies Ltd.	Mainboard	₹655.37 Cr	₹1062	43.47	₹1,438.40	+35.44%	₹2,236.10
Rubicon Research Ltd.	Mainboard	₹1,377.50 Cr	₹485	55.75	₹628.20	+29.53%	₹1,835.40
Bio Medica Laboratories Ltd.	SME	₹52.43 Cr	₹139	13.03	₹115.80	-16.69%	₹158.00
Goldline Pharmaceutical Ltd.	SME	₹11.61 Cr	₹43	10.47	₹56.77	+32.02%	₹36.50
Speciality Medicines Ltd.	SME	₹29.14 Cr	₹124	9.27	₹125.90	+1.53%	₹166.00
Accretion Nutraveda Ltd.	SME	₹24.77 Cr	₹129	26.27	₹191.20	+48.22%	₹270.00
KRM Ayurveda Ltd.	SME	₹77.49 Cr	₹135	17.32	₹180.70	+33.85%	₹307.70
Curis Lifesciences Ltd.	SME	₹27.52 Cr	₹128	12.44	₹141.00	+10.16%	₹198.35
Aptus Pharma Ltd.	SME	₹13.02 Cr	₹70	11.29	₹84.84	+21.20%	₹339.90

Objects of the Issue

#	Issue Objects	Est Amt (₹ Cr.)
1	Funding the working capital requirements.	72.50
2	General corporate purposes.

About Hindustan Laboratories IPO

Updated on Jun 22, 2026

Contact Details

Hindustan Laboratories Ltd. Address302, A Wing,Victory Park, Chandavarkar Road,Borivali West,Mumbai, Maharashtra, 400092022-42460500compliance@hindlab.comVisit Website